<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-02-01" modified="2020-10-07" version="228">
<accession>P40189</accession>
<accession>A0N0L4</accession>
<accession>Q5FC04</accession>
<accession>Q9UQ41</accession>
<name>IL6RB_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="43">Interleukin-6 receptor subunit beta</fullName>
<shortName>IL-6 receptor subunit beta</shortName>
<shortName>IL-6R subunit beta</shortName>
<shortName>IL-6R-beta</shortName>
<shortName>IL-6RB</shortName>
</recommendedName>
<alternativeName>
<fullName>CDw130</fullName>
</alternativeName>
<alternativeName>
<fullName>Interleukin-6 signal transducer</fullName>
</alternativeName>
<alternativeName>
<fullName>Membrane glycoprotein 130</fullName>
<shortName evidence="41">gp130</shortName>
</alternativeName>
<alternativeName>
<fullName>Oncostatin-M receptor subunit alpha</fullName>
</alternativeName>
<cdAntigenName>CD130</cdAntigenName>
</protein>
<gene>
<name type="primary" evidence="44">IL6ST</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Cell" volume="63" first="1149" last="1157">
<title>Molecular cloning and expression of an IL-6 signal transducer, gp130.</title>
<authorList>
<person name="Hibi M."/>
<person name="Murakami M."/>
<person name="Saito M."/>
<person name="Hirano T."/>
<person name="Taga T."/>
<person name="Kishimoto T."/>
</authorList>
<dbReference type="PubMed" id="2261637"/>
<dbReference type="DOI" id="10.1016/0092-8674(90)90411-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT VAL-8</scope>
<scope>SUBUNIT</scope>
<source>
<tissue>Myeloma</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="J. Clin. Invest." volume="106" first="137" last="144">
<title>Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis.</title>
<authorList>
<person name="Tanaka M."/>
<person name="Kishimura M."/>
<person name="Ozaki S."/>
<person name="Osakada F."/>
<person name="Hashimoto H."/>
<person name="Okubo M."/>
<person name="Murakami M."/>
<person name="Nakao K."/>
</authorList>
<dbReference type="PubMed" id="10880057"/>
<dbReference type="DOI" id="10.1172/jci7479"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>VARIANT VAL-8</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Synovium</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2003-02" db="EMBL/GenBank/DDBJ databases">
<title>IL6ST mRNA, nirs splice variant 4.</title>
<authorList>
<person name="Hayashi A."/>
<person name="Sameshima E."/>
<person name="Tabata Y."/>
<person name="Iida K."/>
<person name="Mitsuyama M."/>
<person name="Kanai S."/>
<person name="Furuya T."/>
<person name="Saito T."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="4">
<citation type="submission" date="2006-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Livingston R.J."/>
<person name="Shaffer T."/>
<person name="McFarland I."/>
<person name="Nguyen C.P."/>
<person name="Stanaway I.B."/>
<person name="Rajkumar N."/>
<person name="Johnson E.J."/>
<person name="da Ponte S.H."/>
<person name="Willa H."/>
<person name="Ahearn M.O."/>
<person name="Bertucci C."/>
<person name="Acklestad J."/>
<person name="Carroll A."/>
<person name="Swanson J."/>
<person name="Gildersleeve H.I."/>
<person name="Nickerson D.A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="431" first="268" last="274">
<title>The DNA sequence and comparative analysis of human chromosome 5.</title>
<authorList>
<person name="Schmutz J."/>
<person name="Martin J."/>
<person name="Terry A."/>
<person name="Couronne O."/>
<person name="Grimwood J."/>
<person name="Lowry S."/>
<person name="Gordon L.A."/>
<person name="Scott D."/>
<person name="Xie G."/>
<person name="Huang W."/>
<person name="Hellsten U."/>
<person name="Tran-Gyamfi M."/>
<person name="She X."/>
<person name="Prabhakar S."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chan Y.M."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Martinez D."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nandkeshwar R."/>
<person name="Noonan J.P."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Priest J."/>
<person name="Ramirez L."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="Dickson M."/>
<person name="Cheng J.-F."/>
<person name="Eichler E.E."/>
<person name="Olsen A."/>
<person name="Pennacchio L.A."/>
<person name="Rokhsar D.S."/>
<person name="Richardson P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
</authorList>
<dbReference type="PubMed" id="15372022"/>
<dbReference type="DOI" id="10.1038/nature02919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="8244" last="8253">
<title>Determination of the disulfide structure and N-glycosylation sites of the extracellular domain of the human signal transducer gp130.</title>
<authorList>
<person name="Moritz R.L."/>
<person name="Hall N.E."/>
<person name="Connolly L.M."/>
<person name="Simpson R.J."/>
</authorList>
<dbReference type="PubMed" id="11098061"/>
<dbReference type="DOI" id="10.1074/jbc.m009979200"/>
</citation>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-43; ASN-83; ASN-131; ASN-157; ASN-227; ASN-379; ASN-383; ASN-553 AND ASN-564</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="32635" last="32643">
<title>Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.</title>
<authorList>
<person name="Mosley B."/>
<person name="De Imus C."/>
<person name="Friend D."/>
<person name="Boiani N."/>
<person name="Thoma B."/>
<person name="Park L.S."/>
<person name="Cosman D."/>
</authorList>
<dbReference type="PubMed" id="8999038"/>
<dbReference type="DOI" id="10.1074/jbc.271.51.32635"/>
</citation>
<scope>SUBUNIT</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1997" name="Exp. Hematol." volume="25" first="1367" last="1377">
<title>Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines.</title>
<authorList>
<person name="Hallek M."/>
<person name="Neumann C."/>
<person name="Schaffer M."/>
<person name="Danhauser-Riedl S."/>
<person name="von Bubnoff N."/>
<person name="de Vos G."/>
<person name="Druker B.J."/>
<person name="Yasukawa K."/>
<person name="Griffin J.D."/>
<person name="Emmerich B."/>
</authorList>
<dbReference type="PubMed" id="9406996"/>
</citation>
<scope>INTERACTION WITH HCK</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="22574" last="22582">
<title>Phosphorylation of human gp130 at Ser-782 adjacent to the di-leucine internalization motif. Effects on expression and signaling.</title>
<authorList>
<person name="Gibson R.M."/>
<person name="Schiemann W.P."/>
<person name="Prichard L.B."/>
<person name="Reno J.M."/>
<person name="Ericsson L.H."/>
<person name="Nathanson N.M."/>
</authorList>
<dbReference type="PubMed" id="10811661"/>
<dbReference type="DOI" id="10.1074/jbc.m907658199"/>
</citation>
<scope>PHOSPHORYLATION AT SER-782</scope>
<scope>MUTAGENESIS OF SER-782</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="Eur. J. Biochem." volume="268" first="160" last="167">
<title>Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.</title>
<authorList>
<person name="Jostock T."/>
<person name="Muellberg J."/>
<person name="Ozbek S."/>
<person name="Atreya R."/>
<person name="Blinn G."/>
<person name="Voltz N."/>
<person name="Fischer M."/>
<person name="Neurath M.F."/>
<person name="Rose-John S."/>
</authorList>
<dbReference type="PubMed" id="11121117"/>
<dbReference type="DOI" id="10.1046/j.1432-1327.2001.01867.x"/>
</citation>
<scope>FUNCTION (ISOFORM 2)</scope>
<scope>BIOTECHNOLOGY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="J. Virol." volume="75" first="3325" last="3334">
<title>Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling.</title>
<authorList>
<person name="Li H."/>
<person name="Wang H."/>
<person name="Nicholas J."/>
</authorList>
<dbReference type="PubMed" id="11238858"/>
<dbReference type="DOI" id="10.1128/jvi.75.7.3325-3334.2001"/>
</citation>
<scope>INTERACTION WITH HERPES VIRUS-8/HHV-8 PROTEIN VIL6 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-379 AND ASN-383</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-829</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-667</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-227 AND ASN-390</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="913" last="923">
<title>A strategy for precise and large scale identification of core fucosylated glycoproteins.</title>
<authorList>
<person name="Jia W."/>
<person name="Lu Z."/>
<person name="Fu Y."/>
<person name="Wang H.P."/>
<person name="Wang L.H."/>
<person name="Chi H."/>
<person name="Yuan Z.F."/>
<person name="Zheng Z.B."/>
<person name="Song L.N."/>
<person name="Han H.H."/>
<person name="Liang Y.M."/>
<person name="Wang J.L."/>
<person name="Cai Y."/>
<person name="Zhang Y.K."/>
<person name="Deng Y.L."/>
<person name="Ying W.T."/>
<person name="He S.M."/>
<person name="Qian X.H."/>
</authorList>
<dbReference type="PubMed" id="19139490"/>
<dbReference type="DOI" id="10.1074/mcp.m800504-mcp200"/>
</citation>
<scope>GLYCOSYLATION AT ASN-390</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="1781" last="1789">
<title>N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130.</title>
<authorList>
<person name="Waetzig G.H."/>
<person name="Chalaris A."/>
<person name="Rosenstiel P."/>
<person name="Suthaus J."/>
<person name="Holland C."/>
<person name="Karl N."/>
<person name="Valles Uriarte L."/>
<person name="Till A."/>
<person name="Scheller J."/>
<person name="Grotzinger J."/>
<person name="Schreiber S."/>
<person name="Rose-John S."/>
<person name="Seegert D."/>
</authorList>
<dbReference type="PubMed" id="19915009"/>
<dbReference type="DOI" id="10.1074/jbc.m109.075952"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-667</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="42959" last="42970">
<title>Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.</title>
<authorList>
<person name="Garbers C."/>
<person name="Thaiss W."/>
<person name="Jones G.W."/>
<person name="Waetzig G.H."/>
<person name="Lorenzen I."/>
<person name="Guilhot F."/>
<person name="Lissilaa R."/>
<person name="Ferlin W.G."/>
<person name="Groetzinger J."/>
<person name="Jones S.A."/>
<person name="Rose-John S."/>
<person name="Scheller J."/>
</authorList>
<dbReference type="PubMed" id="21990364"/>
<dbReference type="DOI" id="10.1074/jbc.m111.295758"/>
</citation>
<scope>FUNCTION (ISOFORM 2)</scope>
<scope>BIOTECHNOLOGY</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2013" name="Biochem. J." volume="450" first="487" last="496">
<title>gp130 activation is regulated by D2-D3 interdomain connectivity.</title>
<authorList>
<person name="Schutt A."/>
<person name="Zacharias M."/>
<person name="Schneider N."/>
<person name="Horn S."/>
<person name="Grotzinger J."/>
<person name="Rose-John S."/>
<person name="Schmidt-Arras D."/>
</authorList>
<dbReference type="PubMed" id="23294003"/>
<dbReference type="DOI" id="10.1042/bj20121660"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF CYS-172; 186-TYR--TYR-190; VAL-189; TYR-190; ASP-215 AND VAL-252</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-667 AND SER-839</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-661 AND SER-667</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2015" name="Nature" volume="519" first="57" last="62">
<title>A gp130-Src-YAP module links inflammation to epithelial regeneration.</title>
<authorList>
<person name="Taniguchi K."/>
<person name="Wu L.W."/>
<person name="Grivennikov S.I."/>
<person name="de Jong P.R."/>
<person name="Lian I."/>
<person name="Yu F.X."/>
<person name="Wang K."/>
<person name="Ho S.B."/>
<person name="Boland B.S."/>
<person name="Chang J.T."/>
<person name="Sandborn W.J."/>
<person name="Hardiman G."/>
<person name="Raz E."/>
<person name="Maehara Y."/>
<person name="Yoshimura A."/>
<person name="Zucman-Rossi J."/>
<person name="Guan K.L."/>
<person name="Karin M."/>
</authorList>
<dbReference type="PubMed" id="25731159"/>
<dbReference type="DOI" id="10.1038/nature14228"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF TYR-759</scope>
<scope>INTERACTION WITH SRC AND YES</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2016" name="Cell Rep." volume="14" first="1761" last="1773">
<title>Proteolytic Cleavage Governs Interleukin-11 Trans-signaling.</title>
<authorList>
<person name="Lokau J."/>
<person name="Nitz R."/>
<person name="Agthe M."/>
<person name="Monhasery N."/>
<person name="Aparicio-Siegmund S."/>
<person name="Schumacher N."/>
<person name="Wolf J."/>
<person name="Moeller-Hackbarth K."/>
<person name="Waetzig G.H."/>
<person name="Groetzinger J."/>
<person name="Mueller-Newen G."/>
<person name="Rose-John S."/>
<person name="Scheller J."/>
<person name="Garbers C."/>
</authorList>
<dbReference type="PubMed" id="26876177"/>
<dbReference type="DOI" id="10.1016/j.celrep.2016.01.053"/>
</citation>
<scope>BIOTECHNOLOGY</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2018" name="Sci. Signal." volume="11">
<title>Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses.</title>
<authorList>
<person name="Lamertz L."/>
<person name="Rummel F."/>
<person name="Polz R."/>
<person name="Baran P."/>
<person name="Hansen S."/>
<person name="Waetzig G.H."/>
<person name="Moll J.M."/>
<person name="Floss D.M."/>
<person name="Scheller J."/>
</authorList>
<dbReference type="PubMed" id="30279168"/>
<dbReference type="DOI" id="10.1126/scisignal.aar7388"/>
</citation>
<scope>FUNCTION (ISOFORM 2)</scope>
<scope>BIOTECHNOLOGY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1998" name="EMBO J." volume="17" first="1665" last="1674">
<title>Crystal structure of a cytokine-binding region of gp130.</title>
<authorList>
<person name="Bravo J."/>
<person name="Staunton D."/>
<person name="Heath J.K."/>
<person name="Jones E.Y."/>
</authorList>
<dbReference type="PubMed" id="9501088"/>
<dbReference type="DOI" id="10.1093/emboj/17.6.1665"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 122-325</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2001" name="Science" volume="291" first="2150" last="2155">
<title>Structure of an extracellular gp130 cytokine receptor signaling complex.</title>
<authorList>
<person name="Chow D.-C."/>
<person name="He X.-L."/>
<person name="Snow A.L."/>
<person name="Rose-John S."/>
<person name="Garcia K.C."/>
</authorList>
<dbReference type="PubMed" id="11251120"/>
<dbReference type="DOI" id="10.1126/science.1058308"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 23-325 IN COMPLEX WITH HERPES VIRUS-8/HHV-8 PROTEIN VIL6 (MICROBIAL INFECTION)</scope>
<scope>SUBUNIT</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2003" name="Mol. Cell" volume="12" first="577" last="589">
<title>Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130.</title>
<authorList>
<person name="Boulanger M.J."/>
<person name="Bankovich A.J."/>
<person name="Kortemme T."/>
<person name="Baker D."/>
<person name="Garcia K.C."/>
</authorList>
<dbReference type="PubMed" id="14527405"/>
<dbReference type="DOI" id="10.1016/s1097-2765(03)00365-4"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 123-323 IN COMPLEX WITH LIF</scope>
</reference>
<reference key="31" evidence="3">
<citation type="journal article" date="2003" name="Science" volume="300" first="2101" last="2104">
<title>Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.</title>
<authorList>
<person name="Boulanger M.J."/>
<person name="Chow D.C."/>
<person name="Brevnova E.E."/>
<person name="Garcia K.C."/>
</authorList>
<dbReference type="PubMed" id="12829785"/>
<dbReference type="DOI" id="10.1126/science.1083901"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.65 ANGSTROMS) OF 23-321 IN COMPLEX WITH IL6 AND IL6R</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="21214" last="21218">
<title>Crystal structure of the entire ectodomain of gp130: insights into the molecular assembly of the tall cytokine receptor complexes.</title>
<authorList>
<person name="Xu Y."/>
<person name="Kershaw N.J."/>
<person name="Luo C.S."/>
<person name="Soo P."/>
<person name="Pocock M.J."/>
<person name="Czabotar P.E."/>
<person name="Hilton D.J."/>
<person name="Nicola N.A."/>
<person name="Garrett T.P."/>
<person name="Zhang J.G."/>
</authorList>
<dbReference type="PubMed" id="20489211"/>
<dbReference type="DOI" id="10.1074/jbc.c110.129502"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 24-612</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-43; ASN-83; ASN-227; ASN-383 AND ASN-553</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] ILE-415</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2014" name="Cancer Genet." volume="207" first="291" last="298">
<title>Low incidence of IL6ST (gp130) mutations in exon 6 in lung cancer of a Chinese cohort.</title>
<authorList>
<person name="Sun L."/>
<person name="Sui L."/>
<person name="Cong X."/>
<person name="Ma K."/>
<person name="Ma X."/>
<person name="Huang Y."/>
<person name="Fan C."/>
<person name="Fu X."/>
<person name="Ma K."/>
</authorList>
<dbReference type="PubMed" id="25242236"/>
<dbReference type="DOI" id="10.1016/j.cancergen.2014.07.003"/>
</citation>
<scope>VARIANT GLY-200</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="Metabolism" volume="63" first="647" last="653">
<title>Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels.</title>
<authorList>
<person name="Wonnerth A."/>
<person name="Katsaros K.M."/>
<person name="Krychtiuk K.A."/>
<person name="Speidl W.S."/>
<person name="Kaun C."/>
<person name="Thaler K."/>
<person name="Huber K."/>
<person name="Wojta J."/>
<person name="Maurer G."/>
<person name="Seljeflot I."/>
<person name="Arnesen H."/>
<person name="Weiss T.W."/>
</authorList>
<dbReference type="PubMed" id="24629561"/>
<dbReference type="DOI" id="10.1016/j.metabol.2014.02.005"/>
</citation>
<scope>VARIANT ARG-148</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2017" name="J. Exp. Med." volume="214" first="2547" last="2562">
<title>A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis.</title>
<authorList>
<person name="Schwerd T."/>
<person name="Twigg S.R.F."/>
<person name="Aschenbrenner D."/>
<person name="Manrique S."/>
<person name="Miller K.A."/>
<person name="Taylor I.B."/>
<person name="Capitani M."/>
<person name="McGowan S.J."/>
<person name="Sweeney E."/>
<person name="Weber A."/>
<person name="Chen L."/>
<person name="Bowness P."/>
<person name="Riordan A."/>
<person name="Cant A."/>
<person name="Freeman A.F."/>
<person name="Milner J.D."/>
<person name="Holland S.M."/>
<person name="Frede N."/>
<person name="Mueller M."/>
<person name="Schmidt-Arras D."/>
<person name="Grimbacher B."/>
<person name="Wall S.A."/>
<person name="Jones E.Y."/>
<person name="Wilkie A.O.M."/>
<person name="Uhlig H.H."/>
</authorList>
<dbReference type="PubMed" id="28747427"/>
<dbReference type="DOI" id="10.1084/jem.20161810"/>
</citation>
<scope>VARIANT HIES4 TYR-404</scope>
<scope>INVOLVEMENT IN HIES4</scope>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANT HIES4 TYR-404</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2019" name="Haematologica" volume="104" first="609" last="621">
<title>Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function.</title>
<authorList>
<person name="Shahin T."/>
<person name="Aschenbrenner D."/>
<person name="Cagdas D."/>
<person name="Bal S.K."/>
<person name="Conde C.D."/>
<person name="Garncarz W."/>
<person name="Medgyesi D."/>
<person name="Schwerd T."/>
<person name="Karaatmaca B."/>
<person name="Cetinkaya P.G."/>
<person name="Esenboga S."/>
<person name="Twigg S.R.F."/>
<person name="Cant A."/>
<person name="Wilkie A.O.M."/>
<person name="Tezcan I."/>
<person name="Uhlig H.H."/>
<person name="Boztug K."/>
</authorList>
<dbReference type="PubMed" id="30309848"/>
<dbReference type="DOI" id="10.3324/haematol.2018.194233"/>
</citation>
<scope>VARIANT HIES4 LEU-498</scope>
<scope>INVOLVEMENT IN HIES4</scope>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANT HIES4 LEU-498</scope>
</reference>
<comment type="function">
<text evidence="11 26 29 30 33 35 37">Signal-transducing molecule (PubMed:2261637). The receptor systems for IL6, LIF, OSM, CNTF, IL11, CTF1 and BSF3 can utilize IL6ST for initiating signal transmission. Binding of IL6 to IL6R induces IL6ST homodimerization and formation of a high-affinity receptor complex, which activate the intracellular JAK-MAPK and JAK-STAT3 signaling pathways (PubMed:2261637, PubMed:19915009, PubMed:23294003). That causes phosphorylation of IL6ST tyrosine residues which in turn activates STAT3 (PubMed:19915009, PubMed:23294003, PubMed:25731159). In parallel, the IL6 signaling pathway induces the expression of two cytokine receptor signaling inhibitors, SOCS1 and SOCS3, which inhibit JAK and terminate the activity of the IL6 signaling pathway as a negative feedback loop (By similarity). Also activates the yes-associated protein 1 (YAP) and NOTCH pathways to control inflammation-induced epithelial regeneration, independently of STAT3 (By similarity). Mediates signals which regulate immune response, hematopoiesis, pain control and bone metabolism (By similarity). Has a role in embryonic development (By similarity). Essential for survival of motor and sensory neurons and for differentiation of astrocytes (By similarity). Required for expression of TRPA1 in nociceptive neurons (By similarity). Required for the maintenance of PTH1R expression in the osteoblast lineage and for the stimulation of PTH-induced osteoblast differentiation (By similarity). Required for normal trabecular bone mass and cortical bone composition (By similarity).</text>
</comment>
<comment type="function">
<molecule>Isoform 2</molecule>
<text evidence="17 28 36">Binds to the soluble IL6:sIL6R complex (hyper-IL6), thereby blocking IL6 trans-signaling. Inhibits sIL6R-dependent acute phase response (PubMed:11121117, PubMed:21990364, PubMed:30279168). Also blocks IL11 cluster signaling through IL11R (PubMed:30279168).</text>
</comment>
<comment type="subunit">
<text evidence="11 20 21 29 33 38 39">Component of a hexamer of two molecules each of IL6, IL6R and IL6ST; associates with the complex IL6:IL6R but does not interact with IL6 (PubMed:12829785, PubMed:2261637). Forms heterodimers composed of LIFR and IL6ST (type I OSM receptor) which are activated by LIF and OSM (PubMed:8999038). Also forms heterodimers composed of OSMR and IL6ST (type II receptor) which are activated by OSM but not by LIF (PubMed:8999038). Interacts with HCK (PubMed:9406996). Interacts with INPP5D/SHIP1 (By similarity). Interacts with SRC and YES (PubMed:25731159).</text>
</comment>
<comment type="subunit">
<text evidence="18 19">(Microbial infection) The homodimer binds two molecules of herpes virus 8/HHV-8 protein vIL-6.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1030834">
<id>P40189</id>
</interactant>
<interactant intactId="EBI-1050897">
<id>P26441</id>
<label>CNTF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1030834">
<id>P40189</id>
</interactant>
<interactant intactId="EBI-1030834">
<id>P40189</id>
<label>IL6ST</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1030834">
<id>P40189</id>
</interactant>
<interactant intactId="EBI-22452746">
<id>Q9NZI2-2</id>
<label>KCNIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1030834">
<id>P40189</id>
</interactant>
<interactant intactId="EBI-751501">
<id>Q9Y2W7</id>
<label>KCNIP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1030834">
<id>P40189</id>
</interactant>
<interactant intactId="EBI-1037189">
<id>P15018</id>
<label>LIF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1030834">
<id>P40189</id>
</interactant>
<interactant intactId="EBI-739552">
<id>P43364</id>
<label>MAGEA11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1030834">
<id>P40189</id>
</interactant>
<interactant intactId="EBI-6595724">
<id>P13725</id>
<label>OSM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1030834">
<id>P40189</id>
</interactant>
<interactant intactId="EBI-2804080">
<id>Q99650</id>
<label>OSMR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1030834">
<id>P40189</id>
</interactant>
<interactant intactId="EBI-347996">
<id>O43765</id>
<label>SGTA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1030834">
<id>P40189</id>
</interactant>
<interactant intactId="EBI-744081">
<id>Q96EQ0</id>
<label>SGTB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1030834">
<id>P40189</id>
</interactant>
<interactant intactId="EBI-9007403">
<id>Q2HRC7</id>
<label>K2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1030834">
<id>P40189</id>
</interactant>
<interactant intactId="EBI-602878">
<id>P42227</id>
<label>Stat3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15742214">
<id>P40189-1</id>
</interactant>
<interactant intactId="EBI-1383438">
<id>P23458</id>
<label>JAK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location evidence="26">Cell membrane</location>
<topology evidence="12">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location evidence="31">Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P40189-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P40189-2</id>
<name>2</name>
<name evidence="40">GP130-RAPS</name>
<sequence type="described" ref="VSP_001684 VSP_001685"/>
</isoform>
<isoform>
<id>P40189-3</id>
<name>3</name>
<sequence type="described" ref="VSP_043716"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="29">Found in all the tissues and cell lines examined (PubMed:2261637). Expression not restricted to IL6 responsive cells (PubMed:2261637).</text>
</comment>
<comment type="tissue specificity">
<molecule>Isoform 2</molecule>
<text evidence="31">Expressed in blood serum (at protein level) (PubMed:24629561).</text>
</comment>
<comment type="induction">
<text evidence="38">LIF and OSM activate the type I OSM receptor while only OSM can activate the type II OSM receptor.</text>
</comment>
<comment type="domain">
<text>The WSXWS motif appears to be necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding.</text>
</comment>
<comment type="domain">
<text>The box 1 motif is required for JAK interaction and/or activation.</text>
</comment>
<comment type="PTM">
<text evidence="14">Phosphorylation of Ser-782 down-regulates cell surface expression.</text>
</comment>
<comment type="PTM">
<text evidence="16 19 22 24 25 26">Heavily N-glycosylated (PubMed:11098061, PubMed:16335952, PubMed:19159218, PubMed:19139490, PubMed:11251120). Glycosylation is required for protein stability and localization in plasma membrane but not for ligand binding (PubMed:19915009).</text>
</comment>
<comment type="disease" evidence="35 37">
<disease id="DI-05628">
<name>Hyper-IgE recurrent infection syndrome 4, autosomal recessive</name>
<acronym>HIES4</acronym>
<description>An immunologic disorder characterized by recurrent infections, mainly affecting the respiratory tract, skin and eye, and skeletal abnormalities including craniosynostosis and scoliosis. Immunologic workup shows increased serum IgE, intermittent eosinophilia, impaired development of certain B- and T-cell populations, as well as impaired acute-phase response. Disease onset is in early childhood.</description>
<dbReference type="MIM" id="618523"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="biotechnology">
<text evidence="17 28 34 36">Two extracellular parts of IL6ST/gp130 linked to the Fc-portions of a human IgG1 antibody (sgp130Fc) inhibit IL6 trans-signaling by the IL6:IL6R complex and has no affinity of IL6 or IL6R alone (PubMed:11121117, PubMed:21990364, PubMed:30279168). Also blocks IL11 cluster signaling through IL11R (PubMed:30279168, PubMed:26876177).</text>
</comment>
<comment type="similarity">
<text evidence="43">Belongs to the type I cytokine receptor family. Type 2 subfamily.</text>
</comment>
<dbReference type="EMBL" id="M57230">
<property type="protein sequence ID" value="AAA59155.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB015706">
<property type="protein sequence ID" value="BAA78112.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB102802">
<property type="protein sequence ID" value="BAD89393.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF064722">
<property type="protein sequence ID" value="ABK41905.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC008914">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC016596">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471123">
<property type="protein sequence ID" value="EAW54936.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3971.1">
<molecule id="P40189-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47209.1">
<molecule id="P40189-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54856.1">
<molecule id="P40189-3"/>
</dbReference>
<dbReference type="PIR" id="A36337">
<property type="entry name" value="A36337"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001177910.1">
<molecule id="P40189-3"/>
<property type="nucleotide sequence ID" value="NM_001190981.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002175.2">
<molecule id="P40189-1"/>
<property type="nucleotide sequence ID" value="NM_002184.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_786943.1">
<molecule id="P40189-2"/>
<property type="nucleotide sequence ID" value="NM_175767.2"/>
</dbReference>
<dbReference type="PDB" id="1BJ8">
<property type="method" value="NMR"/>
<property type="chains" value="A=219-325"/>
</dbReference>
<dbReference type="PDB" id="1BQU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=122-333"/>
</dbReference>
<dbReference type="PDB" id="1I1R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=23-325"/>
</dbReference>
<dbReference type="PDB" id="1N2Q">
<property type="method" value="Model"/>
<property type="chains" value="A/B=23-324"/>
</dbReference>
<dbReference type="PDB" id="1P9M">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.65"/>
<property type="chains" value="A=23-321"/>
</dbReference>
<dbReference type="PDB" id="1PVH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/C=123-323"/>
</dbReference>
<dbReference type="PDB" id="3L5H">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A=24-612"/>
</dbReference>
<dbReference type="PDB" id="3L5I">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=323-612"/>
</dbReference>
<dbReference type="PDB" id="3L5J">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.04"/>
<property type="chains" value="A/B=323-610"/>
</dbReference>
<dbReference type="PDBsum" id="1BJ8"/>
<dbReference type="PDBsum" id="1BQU"/>
<dbReference type="PDBsum" id="1I1R"/>
<dbReference type="PDBsum" id="1N2Q"/>
<dbReference type="PDBsum" id="1P9M"/>
<dbReference type="PDBsum" id="1PVH"/>
<dbReference type="PDBsum" id="3L5H"/>
<dbReference type="PDBsum" id="3L5I"/>
<dbReference type="PDBsum" id="3L5J"/>
<dbReference type="BMRB" id="P40189"/>
<dbReference type="SMR" id="P40189"/>
<dbReference type="BioGRID" id="109786">
<property type="interactions" value="38"/>
</dbReference>
<dbReference type="CORUM" id="P40189"/>
<dbReference type="DIP" id="DIP-95N"/>
<dbReference type="IntAct" id="P40189">
<property type="interactions" value="28"/>
</dbReference>
<dbReference type="MINT" id="P40189"/>
<dbReference type="STRING" id="9606.ENSP00000370698"/>
<dbReference type="BindingDB" id="P40189"/>
<dbReference type="ChEMBL" id="CHEMBL3124734"/>
<dbReference type="DrugCentral" id="P40189"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2317"/>
<dbReference type="GlyConnect" id="649">
<property type="glycosylation" value="16 N-Linked glycans (9 sites)"/>
</dbReference>
<dbReference type="GlyGen" id="P40189">
<property type="glycosylation" value="13 sites, 3 N-linked glycans (3 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="P40189"/>
<dbReference type="PhosphoSitePlus" id="P40189"/>
<dbReference type="SwissPalm" id="P40189"/>
<dbReference type="UniCarbKB" id="P40189"/>
<dbReference type="BioMuta" id="IL6ST"/>
<dbReference type="DMDM" id="215273999"/>
<dbReference type="EPD" id="P40189"/>
<dbReference type="jPOST" id="P40189"/>
<dbReference type="MassIVE" id="P40189"/>
<dbReference type="MaxQB" id="P40189"/>
<dbReference type="PaxDb" id="P40189"/>
<dbReference type="PeptideAtlas" id="P40189"/>
<dbReference type="PRIDE" id="P40189"/>
<dbReference type="ProteomicsDB" id="55338">
<molecule id="P40189-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55339">
<molecule id="P40189-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55340">
<molecule id="P40189-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="2448">
<property type="antibodies" value="751 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3572"/>
<dbReference type="Ensembl" id="ENST00000336909">
<molecule id="P40189-1"/>
<property type="protein sequence ID" value="ENSP00000338799"/>
<property type="gene ID" value="ENSG00000134352"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000381287">
<molecule id="P40189-2"/>
<property type="protein sequence ID" value="ENSP00000370687"/>
<property type="gene ID" value="ENSG00000134352"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000381294">
<molecule id="P40189-3"/>
<property type="protein sequence ID" value="ENSP00000370694"/>
<property type="gene ID" value="ENSG00000134352"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000381298">
<molecule id="P40189-1"/>
<property type="protein sequence ID" value="ENSP00000370698"/>
<property type="gene ID" value="ENSG00000134352"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000502326">
<molecule id="P40189-1"/>
<property type="protein sequence ID" value="ENSP00000462158"/>
<property type="gene ID" value="ENSG00000134352"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000522633">
<molecule id="P40189-2"/>
<property type="protein sequence ID" value="ENSP00000435399"/>
<property type="gene ID" value="ENSG00000134352"/>
</dbReference>
<dbReference type="GeneID" id="3572"/>
<dbReference type="KEGG" id="hsa:3572"/>
<dbReference type="UCSC" id="uc003jqq.4">
<molecule id="P40189-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3572"/>
<dbReference type="DisGeNET" id="3572"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000134352.19"/>
<dbReference type="GeneCards" id="IL6ST"/>
<dbReference type="HGNC" id="HGNC:6021">
<property type="gene designation" value="IL6ST"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000134352">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="IL6ST"/>
<dbReference type="MIM" id="600694">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="618523">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P40189"/>
<dbReference type="OpenTargets" id="ENSG00000134352"/>
<dbReference type="PharmGKB" id="PA29837"/>
<dbReference type="eggNOG" id="ENOG502QXEG">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159608"/>
<dbReference type="HOGENOM" id="CLU_017990_0_0_1"/>
<dbReference type="InParanoid" id="P40189"/>
<dbReference type="KO" id="K05060"/>
<dbReference type="OMA" id="YLITVYP"/>
<dbReference type="PhylomeDB" id="P40189"/>
<dbReference type="TreeFam" id="TF338122"/>
<dbReference type="PathwayCommons" id="P40189"/>
<dbReference type="Reactome" id="R-HSA-1059683">
<property type="pathway name" value="Interleukin-6 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-110056">
<molecule id="P40189-1"/>
<property type="pathway name" value="MAPK3 (ERK1) activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-112411">
<molecule id="P40189-1"/>
<property type="pathway name" value="MAPK1 (ERK2) activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6788467">
<property type="pathway name" value="IL-6-type cytokine receptor ligand interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8984722">
<property type="pathway name" value="Interleukin-35 Signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020956">
<property type="pathway name" value="Interleukin-27 signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P40189"/>
<dbReference type="SIGNOR" id="P40189"/>
<dbReference type="BioGRID-ORCS" id="3572">
<property type="hits" value="26 hits in 888 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IL6ST">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P40189"/>
<dbReference type="GeneWiki" id="Glycoprotein_130"/>
<dbReference type="GenomeRNAi" id="3572"/>
<dbReference type="Pharos" id="P40189">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P40189"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="P40189">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000134352">
<property type="expression patterns" value="Expressed in female gonad and 259 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P40189">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P40189">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0070110">
<property type="term" value="C:ciliary neurotrophic factor receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005896">
<property type="term" value="C:interleukin-6 receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005900">
<property type="term" value="C:oncostatin-M receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004897">
<property type="term" value="F:ciliary neurotrophic factor receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005127">
<property type="term" value="F:ciliary neurotrophic factor receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019955">
<property type="term" value="F:cytokine binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004896">
<property type="term" value="F:cytokine receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019838">
<property type="term" value="F:growth factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0019970">
<property type="term" value="F:interleukin-11 binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004921">
<property type="term" value="F:interleukin-11 receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045509">
<property type="term" value="F:interleukin-27 receptor activity"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070120">
<property type="term" value="P:ciliary neurotrophic factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005977">
<property type="term" value="P:glycogen metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070106">
<property type="term" value="P:interleukin-27-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070757">
<property type="term" value="P:interleukin-35-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070102">
<property type="term" value="P:interleukin-6-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060576">
<property type="term" value="P:intestinal epithelial cell development"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048861">
<property type="term" value="P:leukemia inhibitory factor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070104">
<property type="term" value="P:negative regulation of interleukin-6-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038165">
<property type="term" value="P:oncostatin-M-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002675">
<property type="term" value="P:positive regulation of acute inflammatory response"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002821">
<property type="term" value="P:positive regulation of adaptive immune response"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048711">
<property type="term" value="P:positive regulation of astrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010613">
<property type="term" value="P:positive regulation of cardiac muscle hypertrophy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045747">
<property type="term" value="P:positive regulation of Notch signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045669">
<property type="term" value="P:positive regulation of osteoblast differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042102">
<property type="term" value="P:positive regulation of T cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042531">
<property type="term" value="P:positive regulation of tyrosine phosphorylation of STAT protein"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010575">
<property type="term" value="P:positive regulation of vascular endothelial growth factor production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034097">
<property type="term" value="P:response to cytokine"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd00063">
<property type="entry name" value="FN3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="6"/>
</dbReference>
<dbReference type="InterPro" id="IPR003961">
<property type="entry name" value="FN3_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036116">
<property type="entry name" value="FN3_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR003529">
<property type="entry name" value="Hematopoietin_rcpt_Gp130_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR010457">
<property type="entry name" value="IgC2-like_lig-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR015321">
<property type="entry name" value="TypeI_recpt_CBD"/>
</dbReference>
<dbReference type="Pfam" id="PF00041">
<property type="entry name" value="fn3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF09240">
<property type="entry name" value="IL6Ra-bind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF06328">
<property type="entry name" value="Lep_receptor_Ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00060">
<property type="entry name" value="FN3"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49265">
<property type="entry name" value="SSF49265"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="PROSITE" id="PS50853">
<property type="entry name" value="FN3"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS01353">
<property type="entry name" value="HEMATOPO_REC_L_F2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide">
<location>
<begin position="1"/>
<end position="22"/>
</location>
</feature>
<feature type="chain" description="Interleukin-6 receptor subunit beta" id="PRO_0000010899">
<location>
<begin position="23"/>
<end position="918"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="12">
<location>
<begin position="23"/>
<end position="619"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="12">
<location>
<begin position="620"/>
<end position="641"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="12">
<location>
<begin position="642"/>
<end position="918"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type">
<location>
<begin position="26"/>
<end position="120"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 1" evidence="13">
<location>
<begin position="125"/>
<end position="216"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 2" evidence="13">
<location>
<begin position="224"/>
<end position="324"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 3" evidence="13">
<location>
<begin position="329"/>
<end position="424"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 4" evidence="13">
<location>
<begin position="426"/>
<end position="517"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 5" evidence="13">
<location>
<begin position="518"/>
<end position="613"/>
</location>
</feature>
<feature type="short sequence motif" description="WSXWS motif">
<location>
<begin position="310"/>
<end position="314"/>
</location>
</feature>
<feature type="short sequence motif" description="Box 1 motif">
<location>
<begin position="651"/>
<end position="659"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser-rich">
<location>
<begin position="725"/>
<end position="755"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="661"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 8 9 10">
<location>
<position position="667"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="782"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="789"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="829"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="839"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16 27">
<location>
<position position="43"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16 27">
<location>
<position position="83"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="131"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="157"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16 25 27">
<location>
<position position="227"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16 22">
<location>
<position position="379"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16 22 27">
<location>
<position position="383"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine" evidence="24 25">
<location>
<position position="390"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16 27">
<location>
<position position="553"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="564"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16 27">
<location>
<begin position="28"/>
<end position="54"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16 27">
<location>
<begin position="48"/>
<end position="103"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16 27">
<location>
<begin position="134"/>
<end position="144"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16 27">
<location>
<begin position="172"/>
<end position="182"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16 27">
<location>
<begin position="458"/>
<end position="466"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_001684" evidence="40">
<original>RPSKA</original>
<variation>NIASF</variation>
<location>
<begin position="325"/>
<end position="329"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_001685" evidence="40">
<location>
<begin position="330"/>
<end position="918"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_043716" evidence="42">
<location>
<begin position="423"/>
<end position="483"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1063560." id="VAR_047782" evidence="15 29">
<original>L</original>
<variation>V</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; associated with increased levels of soluble IL6RB in blood serum; dbSNP:rs2228044." id="VAR_047783" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patient with lung cancer; unknown pathological significance; dbSNP:rs199905033." id="VAR_074654" evidence="32">
<original>A</original>
<variation>G</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2228043." id="VAR_047784">
<original>L</original>
<variation>V</variation>
<location>
<position position="397"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES4; results in defective cytokine-mediated signaling pathway." id="VAR_083197" evidence="35">
<original>N</original>
<variation>Y</variation>
<location>
<position position="404"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; somatic mutation." id="VAR_036165" evidence="23">
<original>T</original>
<variation>I</variation>
<location>
<position position="415"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2228046." id="VAR_047785">
<original>I</original>
<variation>T</variation>
<location>
<position position="454"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES4; results in defective cytokine-mediated signaling pathway." id="VAR_083198" evidence="37">
<original>P</original>
<variation>L</variation>
<location>
<position position="498"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34417936." id="VAR_047786">
<original>V</original>
<variation>I</variation>
<location>
<position position="499"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces ligand-independent activation." evidence="30">
<original>C</original>
<variation>S</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces ligand-independent activation." evidence="30">
<location>
<begin position="186"/>
<end position="190"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not induce ligand-independent activation." evidence="30">
<original>V</original>
<variation>G</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not induce ligand-independent activation." evidence="30">
<original>Y</original>
<variation>G</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces ligand-independent activation." evidence="30">
<original>D</original>
<variation>G</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces ligand-independent activation." evidence="30">
<original>V</original>
<variation>G</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="mutagenesis site" description="Refractory to inhibition by SOCS3." evidence="33">
<original>Y</original>
<variation>F</variation>
<location>
<position position="759"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases cell surface expression." evidence="14">
<original>S</original>
<variation>A</variation>
<location>
<position position="782"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="28"/>
<end position="35"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="37"/>
<end position="39"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="44"/>
<end position="50"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="52"/>
<end position="58"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="62"/>
<end position="64"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="65"/>
<end position="69"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="76"/>
<end position="78"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="80"/>
<end position="83"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="86"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="97"/>
<end position="107"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="108"/>
<end position="110"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="111"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="130"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="143"/>
<end position="147"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="157"/>
<end position="164"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="176"/>
<end position="178"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="194"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="205"/>
<end position="208"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="212"/>
<end position="214"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="216"/>
<end position="218"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="219"/>
<end position="221"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="226"/>
<end position="231"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="234"/>
<end position="238"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="240"/>
<end position="245"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="248"/>
<end position="251"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="255"/>
<end position="263"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="274"/>
<end position="277"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="282"/>
<end position="286"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="291"/>
<end position="303"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="317"/>
<end position="321"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="325"/>
<end position="331"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="332"/>
<end position="338"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="345"/>
<end position="351"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="356"/>
<end position="359"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="363"/>
<end position="372"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="378"/>
<end position="391"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="396"/>
<end position="406"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="412"/>
<end position="416"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="428"/>
<end position="435"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="438"/>
<end position="444"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="452"/>
<end position="460"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="462"/>
<end position="464"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="469"/>
<end position="474"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="478"/>
<end position="481"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="491"/>
<end position="500"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="508"/>
<end position="515"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="525"/>
<end position="530"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="535"/>
<end position="539"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="544"/>
<end position="547"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="553"/>
<end position="560"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="566"/>
<end position="571"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="575"/>
<end position="579"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="587"/>
<end position="596"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="599"/>
<end position="602"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="606"/>
<end position="609"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1BQU"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1I1R"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1P9M"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1PVH"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3L5I"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18088087"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q00560"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255"/>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00316"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10811661"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10880057"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11098061"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11121117"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11238858"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11251120"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12829785"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14527405"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19139490"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19915009"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20489211"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21990364"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2261637"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23294003"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24629561"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25242236"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25731159"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26876177"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28747427"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30279168"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30309848"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8999038"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9406996"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10880057"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12829785"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="43" type="ECO:0000305"/>
<evidence key="44" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:6021"/>
</source>
</evidence>
<sequence length="918" mass="103537" checksum="6510A4409FFCF08C" modified="2008-11-25" version="2" precursor="true">MLTLQTWLVQALFIFLTTESTGELLDPCGYISPESPVVQLHSNFTAVCVLKEKCMDYFHVNANYIVWKTNHFTIPKEQYTIINRTASSVTFTDIASLNIQLTCNILTFGQLEQNVYGITIISGLPPEKPKNLSCIVNEGKKMRCEWDGGRETHLETNFTLKSEWATHKFADCKAKRDTPTSCTVDYSTVYFVNIEVWVEAENALGKVTSDHINFDPVYKVKPNPPHNLSVINSEELSSILKLTWTNPSIKSVIILKYNIQYRTKDASTWSQIPPEDTASTRSSFTVQDLKPFTEYVFRIRCMKEDGKGYWSDWSEEASGITYEDRPSKAPSFWYKIDPSHTQGYRTVQLVWKTLPPFEANGKILDYEVTLTRWKSHLQNYTVNATKLTVNLTNDRYLATLTVRNLVGKSDAAVLTIPACDFQATHPVMDLKAFPKDNMLWVEWTTPRESVKKYILEWCVLSDKAPCITDWQQEDGTVHRTYLRGNLAESKCYLITVTPVYADGPGSPESIKAYLKQAPPSKGPTVRTKKVGKNEAVLEWDQLPVDVQNGFIRNYTIFYRTIIGNETAVNVDSSHTEYTLSSLTSDTLYMVRMAAYTDEGGKDGPEFTFTTPKFAQGEIEAIVVPVCLAFLLTTLLGVLFCFNKRDLIKKHIWPNVPDPSKSHIAQWSPHTPPRHNFNSKDQMYSDGNFTDVSVVEIEANDKKPFPEDLKSLDLFKKEKINTEGHSSGIGGSSCMSSSRPSISSSDENESSQNTSSTVQYSTVVHSGYRHQVPSVQVFSRSESTQPLLDSEERPEDLQLVDHVDGGDGILPRQQYFKQNCSQHESSPDISHFERSKQVSSVNEEDFVRLKQQISDHISQSCGSGQMKMFQEVSAADAFGPGTEGQVERFETVGMEAATDEGMPKSYLPQTVRQGGYMPQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

